Private Market View

Contraline

Drug Discovery · Charlottesville, VA · Founded 2015 · Privately Held (backing)

Last price · $/share
Implied valuation
$60.0M
Total raised
$41.7M
Last round
Later Stage VC
May 2026
What is Contraline worth?
$60.0Mlast known valuation

Contraline last raised $55.8M in its Later Stage VC (May 2026).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·The complete investor list — 52 names
  • ·Watchlist + deal alerts for Contraline
Create free account
No card required

Funding history

3 rounds
DateRoundRaisedPost-money
May 2026Later Stage VC$55.8M
Apr 2022Later Stage VC$7.2M
Oct 2021Later Stage VC (Series A1)$16.0M

How Contraline's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Contraline, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Contraline worth?
Contraline's last known valuation is $60.0M.
How much has Contraline raised?
Contraline has raised $41.7M in total funding across 3 recorded rounds.
When did Contraline last raise?
Contraline last raised in May 2026 (Later Stage VC), raising $55.8M.